Blog

T cells

Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector

Autolomous LTD, the market leading developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a provider of leading digital enterprise platforms for cell and gene therapy supply chains, today announce a non-exclusive collaborative partnership.

Read More
February 25, 2020

Quality Management Systems for advanced therapies, Part 1: the essentials

Note: this post is the first in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...

February 25, 2020

Quality Management Systems for advanced therapies, Part 2: six areas of focus

Note: this post is the second in a five-part series on Quality Management Systems (including cGMP and Quality Risk Management)...

February 21, 2020

Data management for advanced therapies, Part 8: the benefits of a strategic approach

Note: this post is the eighth in an eight-part series on data management strategies for personalized therapeutics, such as cell...

February 19, 2020

Data management for advanced therapies, Part 7: summing up the strategies

Note: this post is the seventh in an eight-part series on data management strategies for personalized therapeutics, such as cell...

February 12, 2020

Data management for advanced therapies, Part 6: efficiencies across the supply chain

Note: this post is the sixth in an eight-part series on data management strategies for personalized therapies, such as cell...

February 11, 2020

Data management for advanced therapies, Part 5: traceability

Note: this post is the fifth in an eight-part series on data management strategies for personalized therapies, such as cell...

February 5, 2020

Our Series C and the road ahead

Today, we announced Vineti’s $35 million Series C round of investment. A first-of-its-kind investor coalition of industry leaders — Cardinal Health,...

January 30, 2020

Data management for advanced therapies, Part 4: working with multiple stakeholders

Note: this post is the fourth in an eight-part series on data management strategies for personalized therapies, such as cell...

January 8, 2020

Data management for advanced therapies, Part 3: working with living cells

Note: this post is the third in an eight-part series on data management strategies for personalized therapies, such as cell...

December 17, 2019

WoVen, a podcast from Canaan featuring Amy DuRoss

One of Vineti’s board members, Nina Kjellson, General Partner, at Canaan started a podcast called WoVen, about women who venture. We’re excited to...

December 4, 2019

Data management for advanced therapies, Part 2: unique data features

Note: this post is the second of an eight-part series on data management strategies for personalized therapies, such as cell...

December 4, 2019

Data management for advanced therapies, Part 1: the need for new strategies

Note: this post is the first of an eight-part series on data management strategies for personalized therapies, such as cell...